Inhibition of lymphatic metastasis in a syngeneic rat fibrosarcoma model by an angiogenesis inhibitor, AGM-1470

Invasion and Metastasis

Volumn 16, Issue 2, 1996, Pages 73-82

  Futami, Hitoyasu ^a   Iseki, Hideaki ^a   Egawa, Shin Ichi ^a   Koyama, Kotaro ^a   Yamaguchi, Ken ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

AGM 1470; Angiogenesis; Angiogenesis inhibitor; Lymphatic metastasis; Rat fibrosarcoma

Indexed keywords

ANGIOGENESIS INHIBITOR; FUMAGILLOL CHLOROACETYLCARBAMATE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER TRANSPLANTATION; DOSE RESPONSE; FIBROSARCOMA; FOOT PAD; LYMPH NODE METASTASIS; MALE; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CYCLOHEXANES; FIBROSARCOMA; INJECTIONS, SUBCUTANEOUS; LYMPHATIC METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RATS; SESQUITERPENES; TUMOR CELLS, CULTURED;

EID: 0030452904     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hewitt HB, Blake ER: Further studies of the relationship between lymphatic dissemination and lymphnodal metastasis in non-immunogenic murine tumors. Br J Cancer 1977;35:415-419.
2. Tsuruo T, Naganuma K, Iida H, Tsukagoshi S: Lymph node metastasis and effects of 1-beta-D-arabinofuranosylcytosine, 5-fluorouracil, and their lipophilic derivatives in an experimental model system using P388 leukemia. Cancer Res 1980;40:4758-4763.
3. Weiss L, Ward PM: Contributions of vascularized lymph-node metastases to hematogenous metastasis in a rat mammary carcinoma. Int J Cancer 1990;46:452-455.
4. Folkman J: What is the evidence that tumors are angiogenesis dependent? (editorial). J Natl Cancer Inst 1990;82:4-6.
5. Hori A, Sasada R, Matsutani E, Naito K, Sakura Y, Fujita T, Kozai Y: Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibro-blast growth factor. Cancer Res 1991;51:6180-6184.
6. Kandel J, Bossy WE, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D: Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 1991;66:1095-1104.
7. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993;362:841-844.
8. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 1990;348:555-557.
9. Brem H, Folkman J: Analysis of experimental antiangiogenic therapy. J Pediatr Surg 1993;28:445-450.
10. Brem H, Gresser I, Grosfeld J, Folkman J: The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J Pediatr Surg 1993;28:1253-1257.
11. Kamei S, Okada H, Inoue Y, Yoshioka T, Ogawa Y, Toguchi H: Antitumor effects of angiogenesis inhibitor TNP-470 in rabbits bearing VX-2 carcinoma by arterial administration of microspheres and oil solution. J Pharmacol Exp Ther 1993;264:469-474.
12. Takamiya Y, Friedlander RM, Brem H, Malick A, Martuza RL: Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470. J Neurosurg 1993;78:470-476.
13. Yamaoka M, Yamamoto T, Ikeyama S, Sudo K, Fujita T: Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res 1993;53:5233-5236.
14. Yamaoka M, Yamamoto T, Masaki T, Ikeyama S, Sudo K, Fujita T: Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470;AGM-1470). Cancer Res 1993;53:4262-4267.
15. Yanase T, Tamura M, Fujita K, Kodama S, Tanaka K: Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res 1993;53:2566-2570.
16. Tanaka T, Konno H, Matsuda I, Nakamura S, Baba S: Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Cancer Res 1995;55:836-839.
17. Koyama K, Nudelman E, Fukuda M, Hakomori S: Correlation of glycosylation in a membrane protein with a molecular weight of 150,000 with tumorigenic property of rat fibrosarcoma variants. Cancer Res 1979;39:3677-3682.
18. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of radiosensitivity. Cancer Res 1987;47:943-946.
19. Kusaka M, Sudo K, Fujita T, Marui S, Itoh F, Ingber D, Folkman J: Potent anti-angiogenic action of AGM-1470: Comparison to the fumagillin parent. Biochem Biophys Res Commun 1991;174:1070-1076.
20. Egawa S, Tsutsumi M, Konishi Y, Kobari M, Matsuno S, Nagasaki K, Futami H, Yamaguchi K: The role of angiogenesis in the tumor growth of Syrian hamster pancreatic cancer cell line HPD-NR. Gastroenterology 1995;108:1526-1533.
21. Takechi A, Uozumi T, Kawamoto K, Ito A, Kurisu K, Sudo K: Inhibitory effect of TNP-470, a new antiangiogenic agent, on the estrogen-induced rat pituitary tumors. Anti-cancer Res 1994;14:157-162.